Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s):  SZLSF

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is engaged in improving the early detection and management of cancer and other chronic diseases through diagnostics and telehealth programs that provide clinical interventions to assist patients who have cancer (COC Protocol), and help patients reduce the risk of developing late-stage disease (AVRT). Its test, Aristotle, is the first mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. Aristotle uses mRNA technology to identify the molecular signatures of multiple cancer types and is built on the Company's patented technology platform, the Sentinel Principle. The Care Oncology Clinic offers a supervised treatment regimen (the COC Protocol) for people diagnosed with cancer of any type or stage. Its ColonSentry is a proprietary blood test for screening for Colorectal Cancer.


TSX:SZLS - Post by User

Comment by Liked2Thinkon Jul 12, 2021 9:38am
115 Views
Post# 33529220

RE:RE:RE:RE:RE:RE:RE:SZLS

RE:RE:RE:RE:RE:RE:RE:SZLSso they "launched" aristotle April 1, but they didnt launch it then.  you make it sound as if Care was getting something no one else could get.  news flash no one else wanted it.  They need Care to try and sell this thing to the current customers they had in the hopes some other company will view it as a success.  They arent getting something exclusive.

We are suppose to trust the guy that has said ridiculous things about how things are going to go with this company since the day he or she decided to grace us with their precense on this board which started the downward fall of the SP.

wasnt it you with the 4 billion evaluation back when we were $1.50.

and yeah Rebecca didnt say that.  You said that Rebecca said that and how would we trust anything out of you.

your doing the same thing you have done all along.  put unreal expectations out there so each time Stage doesnt meet the BS you create the SP goes lower and lower.

I have asked in 5 separate emails if currently any aristotle tests we being done and in all five I get no answer concerning that subject.  
<< Previous
Bullboard Posts
Next >>